Briefs
Perspectives from 50+ Industry Forecasting Leaders, Highlights from Trinity’s Recent Research Focused on BioPharma Forecasting
In a time of peak uncertainty, forecasters are being called on to answer some of the industry’s toughest questions surrounding the impact of COVID-19.
Trinity is bringing together the latest data on challenges forecasters have been experiencing over the past few weeks. This research activity is a joint project of Trinity’s Forecasting Center of Excellence and its benchmarking division, TGaS Advisors.
Publication Access Form…
Read Now
Briefs
The COVID-19 pandemic continues to have an unprecedented impact on our lives and is disrupting businesses as it spreads worldwide. The social distancing measures that are critically important to address the pandemic present new challenges with patient recruitment for clinical trials, market research, and drug launches.
In this time of uncertainty, Trinity is assessing the impact on market research services including the ability of healthcare providers to participate in research.
In its latest brief, “Impact of COVID-19 on Healthcare Market…
Read Now
Case Studies
Trinity conducted a payer and employer advisory board to understand current perceptions of novel migraine therapies and potential strategies to improve access.
Geographic Scope:
Client Situation
The client wanted to gather the payer and employer perspective on how the migraine landscape is evolving, and pressure test key strategic options as well as messages that they had developed. The employers included: Coca-Cola Company, Metro Nashville Public Schools, St. Louis Community College, and Vibra Healthcare.
Trinity’s Solution
Trinity conducted an unblinded advisory board with a diverse…
Read Now
White Papers
2018 and 2019 were banner years for approvals with over 50 drugs approved by the FDA and the EMA each year. 2020 looks no different. As you prepare for your unique launch in an ever-changing landscape, we understand the challenges you may face: limited resources, lack of prioritization, misalignment, diversity of markets. Based on Trinity’s experience supporting dozens of launches in 2019 alone and through a landmark research study with 30 Chief Commercial Officers (CCOs) who had recently launched a product, we…
Read Now
White Papers
By 2022 Europe is forecast to account for 20% of a global US$1.2 trillion pharmaceutical market. For executives from emerging biopharmaceutical companies planning to develop and commercialize their assets in Europe, the views of biopharmaceutical investors are critical, as investors provide the necessary investments. Additionally, investors who have analyzed numerous biopharmaceutical companies will have valuable experience on what drives commercial success.
In this paper, we aim to understand the views of both investors and biopharmaceutical companies, specifically on the investments…
Read Now
White Papers
Cell and Gene Therapy (CGT) is an exciting new frontier in the biopharmaceutical industry. The novelty of the technology and market introduces many complexities for companies commercializing CGTs.
This white paper analyzes the challenges faced and outlines six key questions to consider for reducing complexity and supporting commercial success:
Are we confident in the supply chain right up until administration of the treatment to the patient? Do we have the right pricing, reimbursement, and evidence model in place, not just…
Read Now
White Papers
New targeted oncology treatment regimens have changed cancer treatment. This white paper charts that development and analyzes five different approaches, providing an overview of how these paradigms determine strategic choices for commercial success. We observe that:
The oncology treatment landscape has five distinct treatment paradigms.
Competition, routes of administration, and market dynamics differ dramatically for each paradigm.
The approach to commercialization needs to differ for each paradigm to increase uptake and ensure successful market penetration.
Download the White Paper…
Read Now
Scientific Publications
This retrospective analysis of medical chart data was performed to compare severity and treatment of gout in patients with or without a history of kidney transplantation (KT).
Authors
Lauren Radeck, Clive M. Mendonca, Isabel Lang, Jeffrey Kent, Brian Lamoreaux, Richard J. Johnson
Journal
American Society of Nephrology Meeting, October 2018
View publication…
Read Now
White Papers
Trinity has worked with over a third of companies with cell and gene therapies (CGTs) on market or in Phase 3 clinical trials. Our work has supported business development, launch planning, evidence generation (HEOR, etc.), market access, pricing, and other critical commercial activities to support the development and launch of these therapies. As such, we have seen CGTs morph from a small niche into possibly the most exciting market in pharma. 2019 is poised to be an inflection point for…
Read Now
Scientific Publications
Hypoactive sexual desire disorder (HSDD) is the most prevalent form of female sexual dysfunction (FSD) in the United States and is characterized by a decrease or lack of sexual desire accompanied by distress. Despite the relatively high prevalence of HSDD in US women 18-44 years of age (∼10%), there is a limited understanding of the condition among physicians.
Authors
Sharon Parish, Zainab Shahpurwala, Amod Athavale, Rahul Ravindranath, Nandini Hadker, and Michelle Lim-Watson
Journal
ISSWSH / ISSM Joint Meeting, March 2019…
Read Now
